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ENVIRONMENTAL FACTORS  
EPIGENETIC (RE) PROGRAMMING Post-translational histone modifications (PTMs)  DNA Methylation (DNMTs) 
Post-traumatic stress 
disorder (PTSD)  
Rett Syndrome (RS)  
Rubinstein-Taybi Syndrome (RTS)  
Depression  
Maternal care / Parental 
abuse  
Psychological stress  
Physical shock  
Neglect / isolation / 
traumatic experiences  
Poor nutrition / toxins / 
tobacco / alcohol  
A covalent modification of DNA catalysed by DNA 
methyltransferases.  
Associated with 
transcriptional 
silencing 
DNMT inhibition blocks memory formation 
Highly dynamic 
process, fully reversible 
Histones are basic proteins that regulate the compactation 
of the chromatin.  
Consolidation of associative memory contextual fear 
and taste memory.   
DISCUSSION AND CONCLUSIONS 
 Environment plays a pivotal role in the development of various brain diseases by affecting epigenetic 
marks.   
The brain is one of the most susceptible tissues since epigenetic changes regulate synaptic plasticity, 
learning and memory and behaviour. That’s why alterations on the epigenome could result in the 
development of brain disorders.                                                                                         
 Adverse antenatal maternal environments, childhood adversity and mental stress cause epigenetic 
changes in specific brain regions leading to adult brain disorders such as PTSD, depression, RS and RTS.  
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INTRODUCTION 
 Epigenetics is a mechanism that regulates gene expression independently of DNA sequence, relaying on DNA methylation, histone 
modifications and RNA interference.  
 We could define epigenetic as an instruction book which tells each cell type how to work. Because our genome is identical in each cell 
type but is the epigenome the one who programs each cell type to operate differently; to increase, downgrade or even silence gene 
expression.  
Epigenetic molecular mechanisms are emerging as an important component of gene regulation in brain function, including synaptic 
plasticity,  learning and memory, and behavior. Changes in epigenetic markings in response to stimuli induce changes in cellular 
physiology or behavior.  
OBJECTIVE  
The aim of this  study is to describe 
the molecular mechanisms involved 
in the epigenetic changes that occurs 
in the brain in normal and 
pathological situations.  
Mental retardation and 
skeletal abnormalities  
mutations in the gene 
encoding the CREB-binding 
protein (CBP)  
 
CBP  histone 
acetylation of lysine 
residues contributing to 
transcriptional activation. 
 
Cognitive deficits  
related to a reduced level 
of available CBP to 
regulate changes in gene 
expression. 
Disturbed fear memory  altered 
epigenetic regulation of gene 
transcription. 
 
PP1  molecular suppressor of 
memory formation and modulator of 
fear memory by PTMs. 
Chronic stress  depression on susceptible 
individuals. 
 
Brain-derived neurotrophic factor (Bdnf)    infused 
in the hippocampus have antidepressant-like effects in 
animal models of depression but its lacking give 
impaired antidepressant responses. 
 
Chronic imipramine (antidepressant) treatment after 
defeat stress downregulates Hdac5 expression and 
increases H3 acetylation. 
Caused by mutations in the X-
linked MECP2  
 
MT  severity of symptoms 
depend on the ratio of inactivation 
of paternally X chromosome,  
in favor of paternal allele (the one 
mutated) in the more severe clinical 
phenotype twin. 
 
DNA methylation status of a 
number of loci vary between the 
twins  epigenetic differences, but 
not genetic differences, are 
associated with the discordance 
between these twins. 
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